BioMarin Pharmaceutical | BMRN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Gilead Sciences USD 152.28B 14.55B 2025-12
Incyte USD 21.73B 3B 2026-05
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 13.34B 800M 2026-05
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.04B 176M 2026-05
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05